The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.
https://www.databridgemarketresearch.com/reports/global-opioid-use-disorder-market/amp
Accessing Buvidal® and Sublocade®
From April 21 2020 Buvidal® and Sublocade® are permitted to be prescribed by all OTP accredited medical or nurse practitioners and non-accredited medical practitioners.
https://www.health.nsw.gov.au/aod/Pages/depot-buprenorphine.aspx
Non-accredited prescribers are permitted to induct and manage up to twenty (20) opioid dependent patients on buprenorphine medicines. This existing restriction in the NSW Clinical Guidelines: Treatment of Opioid Dependence 2018 on patient numbers for non-accredited medical practitioners now include patients on depot buprenorphine.
Non-accredited prescribers are urged to seek clinical advice on prescribing and case management of patients on depot buprenorphine from addiction medicine or addiction psychiatry specialists, their local health district drug and alcohol service, or the Drug and Alcohol Specialist Advisory Service (DASAS).
Prescribers of Buvidal® and Sublocade® will be able to access the medicine through either wholesaler direct delivery from Healthcare Logistics Australia (HCL), or through arrangement with a local pharmacy.
Buvidal® can be accessed by emailing australia@camurus.com.
Sublocade® can be accessed by emailing sublocadeorders@indivior.com or calling 02 9025 0200.
Medical practitioners using direct wholesaler delivery or pharmacy delivery should be aware of the S8 storage requirements.
Pharmacies must make arrangements for delivery to medical clinics and must never dispense depot buprenoprhine to a patient.
Eating in restaurants is SAFER than at home claims top French chef Alain Ducasse
https://www.dailymail.co.uk/news/article-8256715/Eating-restaurants-SAFER-home-claims-French-chef-Alain-Ducasse.html
https://newswelcome.com/2020/04/24/investors-love-this-stock-indivior-plc-lseindv/
Analyst recommended consensus rating of 2.1 on this stock. Analysts also expected that stock to achieve share value at GBX241 +370.75% in coming one year period. EBITDA is $214.000M. EBITDA is a company’s earnings before interest, taxes, depreciation, and amortization and is an accounting measure calculated using a company’s net earnings, before interest expenses, taxes, depreciation and amortization are subtracted, as a proxy for a company’s current operating profitability.
Positive Long-Term Safety Data From Indivior Sublocade Injection Study
https://www.morningstar.co.uk/uk/news/AN_1587035900087025100/positive-long-term-safety-data-from-indivior-sublocade-injection-study.aspx
Indivior Gets Amicus Cut From 3rd Circ. Suboxone Appeal
The Third Circuit has rejected a law professor's brief after Indivior PLC asked that it be struck from its appeal of a ruling certifying a class of Suboxone buyers that allege the company employed a product-hopping scheme to maintain its monopoly on the opioid addiction treatment ...
If they target this big fish in market as they need business .
Chiquito - 79
Frankie & Benny 240
Wagamma 135
Bella Italia 90
JD weather spoon 900 pubs
Gourmet Burger Kitchen
Prezzo 180
Harvester pub - 175
Zizzo 160
GIRAFFE 39
May be Nando's 340
more to come
BIG DISH its a big year 2020
https://m.londonstockexchange.com/exchange/mobile/news/detail/14034737.html
https://m.londonstockexchange.com/exchange/mobile/news/detail/14034972.html
its live website
http://www.tablepouncer.com/london/restaurants/
if you are register you can do the booking instantly
https://www.insidermedia.com/insider/southwest/bigdish-uk-to-consider-sale-of-asia-business
WHAT HAPPENING WITH ASIA BUSINESS SALE ????
http://www.tablepouncer.com/london/restaurants/
Brigton - 6
bath 0
Bournemouth 27
Bristol 3
Edinburgh 0
London 40
Southampton 2
Why Table Pouncer is not meger with Bigdish till date ???